Latest debt-to-equity ratio

Arcutis Biotherapeutics Debt-to-equity ratio

Direct answer

Arcutis Biotherapeutics's debt-to-equity ratio is 51.74%.

The verified market snapshot reports 51.74%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 8, 2026.

Get free Arcutis Biotherapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Debt-to-equity ratio
51.74%